Valsartan dosage forms and strengths

Revision as of 20:16, 24 February 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Valsartan}} {{CMG}}; {{AE}} {{SS}} ==Dosage Forms and Strengths== 40 mg are scored yellow ovaloid tablets with beveled edges, imprinted NVR/DO (Side 1/Side 2) 80...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Valsartan
DIOVAN® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials on Valsartan
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Dosage Forms and Strengths

40 mg are scored yellow ovaloid tablets with beveled edges, imprinted NVR/DO (Side 1/Side 2)

80 mg are pale red almond-shaped tablets with beveled edges, imprinted NVR/DV

160 mg are grey-orange almond-shaped tablets with beveled edges, imprinted NVR/DX

320 mg are dark grey-violet almond-shaped tablets with beveled edges, imprinted NVR/DXL[1]


References

Template:Angiotensin II receptor antagonists